Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 318-326, February 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lasnitzki, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lasnitzki, I.

The Effects of Actinomycin D and Methylcholanthrene on the Cytology and RNA and Protein Synthesis in Prostatic Epithelium Grown in Vitro

Ilse Lasnitzki

Strangeways Research Laboratory, Cambridge, England

The effects of actinomycin D and methylcholanthrene on the cytology of the rat ventral prostate gland grown in vitro have been studied and correlated with changes in RNA and protein synthesis. Prostatic explants were exposed for 2 days to actinomycin D at concentrations of 0.15 and 0.5 µg/ml medium or to a combination of 0.15 µg/ml actinomycin and 4 µg/ml of methylcholanthrene and transferred for 4 or 7 days to control medium or medium containing methylcholanthrene.

A dose of 0.5 µg actinomycin D causes irreversible breakdown of the prostatic epithelium. After a dose of 0.15 µg/ml, the damage is much less marked and is followed by complete recovery and hyperplasia of the prostatic epithelium.

RNA synthesis, determined autoradiographically by uridine-5-3H incorporation, is severely suppressed by 0.15 µg/ml of actinomycin, but it recovers after 4 days and rises to three times the control level after withdrawal of the antibiotic. Protein synthesis, measured by the incorporation of leucine-4,5-3H, is only slightly inhibited by the antibiotic. The difference between the low uridine and high leucine incorporation suggests the existence of long-lived messenger RNA in the prostatic epithelium.

Methylcholanthrene alone induces epithelial hyperplasia which is associated with a gradual increase of uridine incorporation and a transient stimulation of leucine incorporation. Combining methylcholanthrene with actinomycin prevents the cellular damage produced by actinomycin alone, allows cell multiplication to proceed, and partially inhibits the suppression of uridine incorporation by the antibiotic. After transfer to medium containing methylcholanthrene but no antibiotic, the hyperplasia is accelerated and increased as compared with that seen after continuous treatment with methylcholanthrene alone. The interaction between methylcholanthrene and actinomycin D is discussed in the context of possible hydrocarbon binding sites in the cell nucleus.

Received 7/11/68. Accepted 9/20/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.